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Soil-Transmitted Helminths
Richard R. Roach
Abstract
Helminths currently affect over 2 billion people worldwide with a quarter of the 
world’s population infected at some time in their lives. Sobering statistics from the 
WHO March 2008 report that 80% of the “Bottom Billion” impoverished popula-
tion of the world have Ascaris, 60% have Trichuris, and 57% have hookworms. This 
would only be a problem of pharmacologic distribution if not for an additional 
report demonstrating that several new studies reported to the WHO claim a 50% 
failure rate clearing Trichuris and 90% failure rate clearing hookworm. These 
parasitic infections pose a challenge to tropical physicians who have considered 
mebendazole and albendazole as adequate treatments for children. This is even 
more of a challenge for physicians in temperate climates who may be less familiar 
with these medications. This article presents the recent data and the approach to 
treatment failure and new therapeutic approaches.
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1. Introduction
Intestinal parasites cause substantial morbidity and mortality, particularly in 
children in whom they have detrimental effects on growth and cognitive perfor-
mance. Parasitic infestation leads to deformity and long-term disabilities and often 
stigmatizes the child. Parasitized pregnant women are anemic, have increased fetal 
wastage, and have low birth weight newborns. Though tropical diseases affect a 
large proportion of the world’s population, less than 1% of new drug development 
over the past 30 years focused on tropical diseases. Recent philanthropic interest has 
resulted in research, long tardy, for these diseases.
2. Epidemiology
There are three soil-transmitted helminth infections, Ascaris lumbricoides, 
hookworm (Ancylostoma duodenale and Necator americanus), and Trichuris trichi-
ura, labeled by the WHO as the “Unholy Trinity.” They are ubiquitous in tropical 
climates and even temperate rural areas in poverty-stricken communities with poor 
sanitation (see Table 1). Ascaris and Trichuris increase in prevalence from infancy 
to puberty and then decrease in adulthood. In contrast, hookworm, the leading 
cause of anemia throughout the world, continues to increase through life, not 
reaching a plateau until age 40. This characteristic has a profound effect on women 
of childbearing age and is associated with small-for-gestation newborns as well as 
increasing fetal loss.
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3. Management
The WHO has classified parasitic infestation by egg intensity to clarify symp-
tomatic and asymptomatic infestations (see Table 2). Children with light worm 
loads are often asymptomatic, but children form the greatest population of the 
heavy intensity group. Even children considered asymptomatic may have subtle 
differences in learning and intellectual achievement [1].
The clinical presentation relates to parasite migration in the skin, viscera, and 
gastrointestinal tract. Trichuris and Ascaris are a result of fecal-oral ingestion. 
Wheezing, dyspnea, nonproductive cough, fever, bloody sputum, chest x-ray 
infiltrates, and systemic eosinophilia result during pulmonary vascular migration. 
Once swallowed the larvae mature, and their migration in the gut causes abdominal 
pain, distention, and malabsorption.
If adult Ascaris migrate into the biliary tree, then pancreatitis, cholangitis, and 
cholecystitis result. Hepatic abscesses and appendicitis may result from Ascaris 
migration. In younger children, heavy loads of worms can cause partial or complete 
bowel obstruction in the ileum. Swelling of Peyer’s patches leads to an increased risk 
of intussusception and volvulus. Unrecognized obstruction may eventually cause 
bowel infarction and perforation with resulting peritonitis.
Trichuris may infect any part of the colon, but the parasite prefers the cecum. 
Eggs release the larvae in the small intestine, and the worms mature in the colon 
where they tunnel into the mucosa, causing inflammation. Heavy infestation causes 
a dysentery syndrome severe enough that it may result in rectal prolapse. Impaired 
growth and anemia are the consequences of chronic infestation.
Hookworm infects through skin penetration. Itching erythematous rash from 
multiple skin penetrations causes severe pruritus of the skin, usually on the feet 
or hands. The larvae use the pulmonary vasculature to access the bronchial secre-
tions and then, when swallowed, mature into adults in the gastrointestinal tract. 
Bronchial migration presents as clinical pneumonitis but may be mistaken for 
asthma. Pulmonary symptoms are seldom as dramatic as with Ascaris. The signifi-
cant sequelae of infection relate to intestinal blood loss. As few as 40 worms can 
reduce the hemoglobin below 11 g/dl. Heavy infestations lead to loss of protein with 
resulting loss of plasma osmotic pressure and anasarca.
Helminth infestations cause anemia and malnutrition, growth stunting, and 
cognitive deficits, associated with poor school attendance and performance. Since 
this occurs in an impoverished area where the diet has limited resource to protein, 
the consequences of the poor child’s limited diet magnifies the malnutrition. If 
this occurs in a malaria area, the anemia caused by helminths exaggerates the 
anemia of malaria.
Disease Global 
prevalence 
(millions) [1]
Population at 
risk (billions)
Estimated global 
disease burden 
(disability-adjusted life 
years in millions)
Vulnerable population
Ascariasis 807 4.2 1.8–10.5 School-age children
Trichuriasis 604 3.2 1.8–6.4 School-age children
Hookworm 576 3.2 1.5–22.1 School-age children, women 
of reproductive age
Table 1. 
Impact of soil-transmitted helminths [2].
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This is especially crucial for women of childbearing age, since infected women 
were 2.6 times more likely to have preterm deliveries and 3.5 times more likely to 
have small-for-gestational age infants. If the woman lives in a malaria-endemic 
area, the risks of malaria increase the infant mortality.
4. Treatment
There are four medications currently available to treat soil-transmitted helminth 
infections (see Table 3). Benzimidazoles impede the microtubular system, in 
particular β-tubulin, in the worm. Since this is not a host system, patients tolerate 
these drugs with minimal side effects. Very few patients report nausea, vomiting, 
and headache, but allergic reactions with fever are rare. Levamisole and pyrantel 
pamoate are nicotinic acetylcholine receptor agonists, which paralyze the worms 
and precipitate their expulsion. Gastrointestinal symptoms, headache, dizziness, 
fever, and rash are usually mild and self-limited. However, a bulk of paralyzed 
worms increases the risk of a bowel obstruction.
The most important aspect of treatment is efficacy. Cure rates and egg reduction 
rates are high for all four drugs when treating Ascaris (see Table 4). Nevertheless, 
recent studies have documented ineffective and inconsistent treatment of Trichuris 
and hookworm, whether Ancylostoma duodenale or Necator americanus. The concern 
is drug resistance, despite lack of previous investigation. Researchers presumed 
that the drugs were effective in the past because they were effective with the other 
Intensity Ascaris Hookworms Trichuris
Light 1–4999 epg 1–1999 epg 1–999 epg
Moderate 5000–49,999 epg 2000–3999 epg 1000–9999 epg
Heavy ≥50,000 epg ≥4000 epg ≥10,000 epg
Epg: eggs per gram of feces.
Table 2. 
Soil-transmitted helminth infection intensity [3].
Infection Drug Dose
Ascariasis Albendazole* 400 mg once
Mebendazole 100 mg twice daily × 3 days or 500 mg once
Pyrantel pamoate 11 mg/kg (max 1 g) × 3 days
Levamisole 2.5 mg/kg once
Hookworm Albendazole* 400 mg once
Mebendazole 100 mg twice daily × 3 days
Pyrantel pamoate 11 mg/kg (max 1 g) × 3 days
Levamisole 2.5 mg/kg once, repeat after 7 days for heavy infection
Trichuris Mebendazole 100 mg twice daily × 3 days or 500 mg once
Albendazole* 400 mg × 3 days
*In children 1–2 years old, use 200 mg.
Table 3. 
Treatment of soil-transmitted helminth infections [6].
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helminths. Recent studies by veterinarians tested efficacy in mass drug admin-
istration to animals in endemic areas. Such studies presumed human efficacy. 
Subsequent studies done in adults excluded children and pregnant women, the most 
at-risk populations.
Currently, research established benzimidazoles as safe for children greater 
than 1 year of age. Teratogenic potential seen in animal studies requires careful 
Table 4. 
Efficacy of single- and multiple-dose anthelminthic drugs against common soil-transmitted helminth infections [4].
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assessment of benefit/risk ratio. The WHO does recommend treatment of hook-
worm in pregnancy due to the adverse effect of anemia which is greater than the 
risk of the medication [2]. Limited studies show no congenital anomalies or perina-
tal mortality with the use of albendazole, mebendazole, or ivermectin, although use 
in the first trimester is still discouraged. Studies have yet to focus on levamisole and 
pyrantel in pregnancy [2].
5. Prevention
Because of the large burden of disease, prevention needs to be the foremost consid-
eration in improving community health. Sanitation, access to a clean source of water, 
and careful food preparation limit fecal-oral contamination. Careful disposal of feces 
decreases exposure to helminthic eggs, and footwear limits hookworm exposure.
The other approach has been to limit morbidity through periodic treatment. The 
school system has been the logical institution for community treatment. Many stud-
ies have employed deworming schoolchildren on an annual basis, while others have 
focused on women of reproductive age. One recent study focused on community 
versus schoolchildren treatment justified a strategy that involves the entire com-
munity [3]. Community treatment in several studies documents the requirement to 
reach at least 75% of the at-risk population. Governments willing to institute such 
programs recognize the cost of $0.02 USD. Several pharmaceutical companies made 
the drugs affordable. One example, a study done in Zanzibar, examined the co-
administration of ivermectin, albendazole, and praziquantel in 5055 children and 
adults. This mass drug administration benefitted the entire community.
6. Future research and treatment
Considering the high prevalence of soil-transmitted helminths and the estab-
lished resistance, there is a need for other treatment options. This has provoked 
enthusiasm for vaccines and drugs with novel mechanisms of action. Unfortunately, 
there has been little financial incentive for developing human vaccines and novel 
drugs for poverty-stricken areas, but veterinary medicine has the financial incentive 
of herd treatment.
The nicotinic acetylcholine receptor is unique to helminths and nematodes, 
although it appears to be a malaria parasite receptor as well. Since this receptor does 
not exist in humans, a medication to block this receptor should be effective and well 
tolerated. A vaccine with an antibody against this receptor seems a logical potential 
step for research. Tribendimidine is an L-type nicotinic acetylcholine receptor 
agonist. It is very effective in animals. Clinical trial in humans resulted in approval 
in China in 2004. Despite the difference in chemical structure and the hypothesized 
receptor agonist effect, it proved to have the same mechanism of action as benz-
imidazoles and showed no advantage in humans.
Monepantel is a nicotinic acetylcholine receptor agonist. It is highly effective and 
licensed for sheep. Researchers initiated studies in humans. It does appear to have 
a unique mechanism of action since in animals it has been effective in multidrug 
resistant nematode infections it may also be effective in humans with resistant 
infestations.
Developing a vaccine requires an antigen. Developers have struggled with which 
antigen to use that will allow a sufficient and effective antigenic response. Vaccines 
developed for soil-transmitted helminths are effective in newborn animals. A 
vaccine to the hookworm antigen, Na-ASP-2, is effective in dogs [4]. Vaccinated 
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while still puppies, they were resistant to hookworm infection. This success led 
to a limited phase 1 trial in Brazil. Unfortunately, 30% of the patients developed 
urticaria, and one patient developed anaphylaxis. These reactions stopped the trial. 
Speculation as to the cause of this intense reaction led to the hypothesis that the 
study patients had antibodies to the antigen because of previous exposure from 
residing in an endemic area. Like the puppies, the requirement must to vaccinate 
human subjects prior to antigenic exposure [5].
7. Conclusions
Helminth infections are a common problem. Presumed effectiveness of drugs 
is a deficient hypothesis. The available medications are not as effective as once 
thought. The trials of mass treatment of schoolchildren do not exterminate the 
source of infection or resolve the community exposure. New medication research is 
essential, especially for Trichuris. Novel treatments such as vaccines may be on the 
horizon, but safety concerns for humans with previous exposure is an important 
immunologic problem. Sanitation is still the most important community solution. 
The recent disaster in Port-au-Prince, Haiti, demonstrated that without sewer 
systems and potable water, we humans are indeed a vulnerable species.
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